( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
749.08
715.16
561.38
984.3
Total Expenditure
886.84
761.28
837.96
1406.61
PBIDT (Excl OI)
-137.76
-46.12
-276.58
-422.31
Other Income
96.44
110.01
597.12
363.64
Operating Profit
-41.31
63.89
320.54
-58.65
Interest
53.28
44.06
49.94
-74.81
Exceptional Items
NA
NA
NA
NA
PBDT
-94.59
19.83
270.6
16.15
Depreciation
16.54
16.08
15.2
171.27
Profit Before Tax
-111.13
3.74
255.4
-155.12
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-105.63
-13.64
236.77
-127.23
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-105.63
-13.64
236.77
-122.64
Minority Interest
NA
NA
NA
NA
Shares of Associates
17.6
13.46
-35.37
116.59
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-88.03
-0.17
201.4
-6.05
Equity Capital
977.9
977.9
977.9
977.9
Calculated EPS
-0.18
-0.00
0.41
-0.01
Calculated EPS (Annualised)
-0.72
-0.00
1.64
-0.04
No of Public Share Holdings
52576348
52576348
52576348
52576348
% of Public Share Holdings
10.75
10.75
10.75
10.75
PBIDTM% (Excl OI)
-18.39
-6.44
-49.26
-42.90
PBIDTM%
-5.51
8.93
57.09
-5.95
PBDTM%
-12.62
2.77
48.20
1.64
PBTM%
-14.83
0.52
45.49
-15.75
PATM%
-14.10
-1.90
42.17
-12.92